Hc. Diener et al., Therapy of migraine attack and migraine prophylaxis - Recommendations of the German Migraine and Headache Society, NERVENHEILK, 19(6), 2000, pp. 335-345
The incidence of migraine is 6-8% for men and 12-14% for women. Migraine at
tacks lead to pulsating and throbbing hemicrania with autonomic disturbance
s. Up to 15% of patients suffer from migraine with aura with visual disturb
ances prior to headache. Mild to moderate attacks are treated with antiemet
ics (metoclopramide or domperidone) in combination with analgesics (aspirin
, paracetamol, ibuprofen, naproxen, diclofenac). Moderate and severe attack
s ore treated with 5-HT1B/1D receptor agonists ("triptans"). Ergots in comb
ination with antiemetics ore less effective than triptans. Patients with fr
equent and severe attacks need medical and non-pharmacological migraine pro
phylaxis. Drugs of first choice ore the betablockers metoprolol and propran
olol and the calcium channel blocker flunarizine. Drugs of second choice or
e valproic acid and non-steroidal antiinflammatory drugs. Nonmedical treatm
ent includes relaxation techniques combined with cognitive therapy, stress
mamagement and sport therapy.